Membranoproliferative glomerulonephritis: Difference between revisions
Ahmed Younes (talk | contribs) No edit summary |
No edit summary |
||
(30 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
<div style="-webkit-user-select: none;"> | <div style="-webkit-user-select: none;"> | ||
{|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right; | {| class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;" | ||
|- | |- | ||
| {{#ev:youtube|https://https://www.youtube.com/watch?v= | |{{#ev:youtube|https://https://www.youtube.com/watch?v=uriIHhO5kVQ|350}} | ||
|- | |- | ||
|} | |} | ||
Line 21: | Line 21: | ||
}} | }} | ||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
{{CMG}} {{APM}}; '''Associate Editor-In-Chief:''' {{OO}}{{CZ}} | {{CMG}} {{APM}}; '''Associate Editor-In-Chief:''' {{OO}}{{CZ}} {{N.F}}{{JSS}} [https://www.wikidoc.org/index.php?title=L.Farrukh&action=edit&redlink=1 <nowiki>L.Farrukh [6]</nowiki>] | ||
== [[Membranoproliferative glomerulonephritis overview|Overview]] == | ==[[Membranoproliferative glomerulonephritis overview|Overview]]== | ||
==[[Membranoproliferative glomerulonephritis historical perspective|Historical Perspective]]== | |||
==[[Membranoproliferative glomerulonephritis classification|Classification]]== | |||
== [[Membranoproliferative glomerulonephritis | ==[[Membranoproliferative glomerulonephritis pathophysiology|Pathophysiology]]== | ||
== [[Membranoproliferative glomerulonephritis | ==[[Membranoproliferative glomerulonephritis causes|Causes]]== | ||
==[[Membranoproliferative glomerulonephritis differential diagnosis|Differentiating Membranoproliferative glomerulonephritis from other Diseases]]== | |||
== [[Membranoproliferative glomerulonephritis | ==[[Membranoproliferative glomerulonephritis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Membranoproliferative glomerulonephritis risk factors|Risk Factors]]== | |||
== [[Membranoproliferative glomerulonephritis | ==[[Membranoproliferative glomerulonephritis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
| [[Membranoproliferative glomerulonephritis electrocardiogram|Electrocardiogram]] | [[Membranoproliferative glomerulonephritis chest x ray|Chest X Ray]] | [[Membranoproliferative glomerulonephritis CT|CT]] | [[Membranoproliferative glomerulonephritis MRI|MRI]] | [[Membranoproliferative glomerulonephritis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Membranoproliferative glomerulonephritis other imaging findings|Other Imaging Findings]] | [[Membranoproliferative glomerulonephritis other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
== Treatment == | |||
[[Membranoproliferative glomerulonephritis medical therapy|Medical Therapy]] | [[Membranoproliferative glomerulonephritis surgery|Surgery]] | [[Membranoproliferative glomerulonephritis primary prevention|Primary Prevention]] | [[Membranoproliferative glomerulonephritis secondary prevention|Secondary Prevention]] | [[Membranoproliferative glomerulonephritis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Membranoproliferative glomerulonephritis future or investigational therapies|Future or Investigational Therapies]] | [[Membranoproliferative glomerulonephritis medical therapy|Medical Therapy]] | [[Membranoproliferative glomerulonephritis surgery|Surgery]] | [[Membranoproliferative glomerulonephritis primary prevention|Primary Prevention]] | [[Membranoproliferative glomerulonephritis secondary prevention|Secondary Prevention]] | [[Membranoproliferative glomerulonephritis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Membranoproliferative glomerulonephritis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
{{Nephrology}} | {{Nephrology}} | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Line 71: | Line 57: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
<references /> |
Latest revision as of 15:18, 6 September 2020
https://https://www.youtube.com/watch?v=uriIHhO5kVQ%7C350}} |
Membranoproliferative glomerulonephritis | |
ICD-10 | N00-N08 with .2 suffix |
---|---|
ICD-9 | 581.2, 582.2, 583.2 |
MeSH | D015432 |
Membranoproliferative glomerulonephritis Microchapters |
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Membranoproliferative glomerulonephritis On the Web |
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis |
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Risk calculators and risk factors for Membranoproliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor-In-Chief: Olufunmilola Olubukola M.D.[3]Cafer Zorkun, M.D., Ph.D. [4] Nazia Fuad M.D. Jogeet Singh Sekhon, M.D. [5] L.Farrukh [6]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Membranoproliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
| Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies